Holen Sie sich die Stockscreener-App
3.44
0.29%
-0.01
Schlusskurs vom Vortag:
$3.45
Offen:
$3.45
24-Stunden-Volumen:
6,128
Relative Volume:
0.11
Marktkapitalisierung:
$45.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.59M
KGV:
-0.0963
EPS:
-35.74
Netto-Cashflow:
$-19.79M
1W Leistung:
+2.08%
1M Leistung:
-16.50%
6M Leistung:
-36.30%
1J Leistung:
+11.33%
1-Tages-Spanne:
$3.40
$3.45
1-Wochen-Bereich:
$3.27
$3.47
52-Wochen-Spanne:
$2.68
$8.38
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Vergleichen Sie CALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CALC | 3.44 | 45.84M | 0 | -13.59M | -19.79M | -35.74 |
| VRTX | 450.00 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.18 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.92 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.91 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.22 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
CalciMedica to Present CRAC Channel Therapy Updates at Piper Sandler Healthcare Conference | CALC Stock News - StockTitan
CalciMedica Announces Presentations at Upcoming Medical Meetings - StockTitan
Insiders Bet Big on These Small Cap Stocks - MSN
CalciMedica Launches $10M+ Public Stock Offering BIOPHARMA: Propelling Calcium-Based Drug Platform By JENNIFER KASTNER - San Diego Business Journal
CalciMedica’s (CALC) “Buy” Rating Reiterated at HC Wainwright - Defense World
CalciMedica reports Q3 EPS (50c), consensus (50c) - TipRanks
CalciMedica's Auxora Shows 100% Risk Reduction in Respiratory Failure, Extends Cash Runway | CALC Stock News - StockTitan
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PR Newswire
CalciMedica Appoints Stephen Bardin as New CFO - TipRanks
CalciMedica Appoints Chief Financial Officer - Contract Pharma
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer - Citizentribune
CalciMedica Names Ex-atai Life Sciences CFO to Lead Financial Strategy Amid Clinical Trials | CALC Stock News - StockTitan
CalciMedica director Fred Middleton acquires shares valued at $404,040 - Investing.com India
CalciMedica director Fred Middleton acquires shares valued at $404,040 By Investing.com - Investing.com Australia
CalciMedica sees significant stock purchase by Sanderling Ventures - Investing.com Canada
H.C. Wainwright cuts CalciMedica stock target to $16, keeps Buy rating - Investing.com Australia
Graybug Vision Suspends Stock Offering Amid Proposed Public Offering of CalciMedica - Defense World
Calcimedica director Robert Wilson acquires $199,998 in stock - Investing.com India
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock By Investing.com - Investing.com Australia
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock By Investing.com - Investing.com Australia
Calcimedica director Robert Wilson acquires $199,998 in stock By Investing.com - Investing.com Australia
Director Robert Wilson Acquires 53,333 Shares of CalciMedica Inc (CALC) - GuruFocus.com
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock - Investing.com
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock - Investing.com
CalciMedica announces proposed public offering of common stock - MSN
CalciMedica Announces Pricing of Public Offering of Common Stock - StockTitan
CalciMedica launches public stock offering - Investing.com
CalciMedica launches public stock offering By Investing.com - Investing.com UK
CalciMedica Announces Proposed Public Offering of Common Stock - StockTitan
CalciMedica, Inc. (NASDAQ:CALC) Sees Significant Decline in Short Interest - MarketBeat
CalciMedica’s Promising Phase 2b Trial Results for Auxora - TipRanks
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - PR Newswire
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - Citizentribune
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
CalciMedica (NASDAQ:CALC) Stock Price Up 1% – Here’s What Happened - Defense World
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - StockTitan
Scientech Research LLC Buys New Position in Grand Canyon Education, Inc. (NASDAQ:LOPE) - Defense World
Kenvue Inc. (NYSE:KVUE) Shares Bought by Brandes Investment Partners LP - Defense World
Regal Investment Advisors LLC Has $7.19 Million Holdings in AT&T Inc. (NYSE:T) - Defense World
LandBridge (NYSE:LB) and Texas Pacific Land (NYSE:TPL) Financial Comparison - Defense World
Baozun Inc. (NASDAQ:BZUN) Short Interest Update - Defense World
CalciMedica, Inc. (NASDAQ:CALC) Short Interest Up 5.1% in September - Defense World
Likewise Group (LON:LIKE) Stock Price Up 3.1% Following Dividend Announcement - Defense World
Senator Investment Group LP Acquires New Position in CleanSpark, Inc. (NASDAQ:CLSK) - Defense World
Evergreen Capital Management LLC Takes Position in IAC Inc. (NASDAQ:IAC) - Defense World
Caxton Associates LP Sells 4,741 Shares of Verizon Communications Inc. (NYSE:VZ) - Defense World
Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga
Acute Pancreatitis Market Business Insights, Key Trend Analysis - Economica
CalciMedica (NASDAQ:CALC) Shares Down 2% - Defense World
CalciMedica (NASDAQ:CALC) Trading Down 2% - Defense World
Allegiant Travel (NASDAQ:ALGT) Issues Q3 2024 Earnings Guidance - MarketBeat
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):